Gene · 8647
Papers3,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,310
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The gut-liver axis in hepatobiliary diseases. | Inflamm Regen | 2024 | 38191517 | PubTator, text mining | PubMed |
| Maternal and neonatal outcomes of intrahepatic cholestasis of pregnancy after in vitro fertilization. | BMC Pregnancy Childbirth | 2024 | 38191339 | PubTator, text mining | PubMed |
| Bile salt signaling and bile salt-based therapies in cardiometabolic disease. | Clin Sci (Lond) | 2024 | 38180064 | PubTator, text mining | PubMed |
| Impact of perfluoroalkyl substances (PFAS) and PFAS mixtures on lipid metabolism in differentiated HepaRG cells as a model for human hepatocytes. | Arch Toxicol | 2024 | 38117326 | PubTator, text mining | PubMed |
Molecular and computational characterization of ABCB11 and ABCG5 variants in Tunisian patients with neonatal/infantile low-GGT intrahepatic cholestasis: Genetic diagnosis and genotype-phenotype correlation assessment. | Ann Hum Genet | 2024 | 38108658 | PubTator, text mining | PubMed |
| Hepatotoxicity of cyanotoxin microcystin-LR in human: Insights into mechanisms of action in the 3D culture model Hepoid-HepaRG. | Environ Pollut | 2024 | 38036087 | PubTator, text mining | PubMed |
| Identification of Proteome-Based Immune Subtypes of Early Hepatocellular Carcinoma and Analysis of Potential Metabolic Drivers. | Mol Cell Proteomics | 2024 | 38008179 | PubTator, text mining | PubMed |
| Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells. | Oncol Rep | 2024 | 37975256 | PubTator, text mining | PubMed |
| Simulation-based mastery learning for intrathecal baclofen pump management in physical medicine and rehabilitation: A pilot study. | PM R | 2024 | 37924524 | PubTator, text mining | PubMed |
A Prospective Study Measuring Resident and Faculty Contour Concordance: A Potential Tool for Quantitative Assessment of Residents' Performance in Contouring and Target Delineation in Radiation Oncology Residency. | J Am Coll Radiol | 2024 | 37844655 | PubTator, text mining | PubMed |
| Ursolic acid attenuates cholestasis through NRF2-mediated regulation of UGT2B7 and BSEP/MRP2. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 37812240 | PubTator, text mining | PubMed |
| Clinical, histopathological, and immunohistochemical spectrum of hepatolithiasis: a tertiary care center-based study from north India. | Virchows Arch | 2024 | 37550583 | PubTator, text mining | PubMed |
| Ligand- and Structure-based Approaches for Transmembrane Transporter Modeling. | Curr Drug Res Rev | 2024 | 37157206 | PubTator, text mining | PubMed |
| The causal effect of HbA1c on white matter brain aging by two-sample Mendelian randomization analysis. | Front Neurosci | 2023 | 38274506 | PubTator, text mining | PubMed |
| The maternal hair metabolome is capable of discriminating intrahepatic cholestasis of pregnancy from uncomplicated pregnancy. | Front Endocrinol (Lausanne) | 2023 | 38260149 | PubTator, text mining | PubMed |
| A Comprehensive Metabolism-Related Gene Signature Predicts the Survival of Patients with Acute Myeloid Leukemia. | Genes (Basel) | 2023 | 38254953 | PubTator, text mining | PubMed |
| Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy. | Int J Mol Sci | 2023 | 38203175 | PubTator, text mining | PubMed |
| Primary biliary cirrhosis and osteoporosis: a bidirectional two-sample Mendelian randomization study. | Front Immunol | 2023 | 38162659 | PubTator, text mining | PubMed |
| Totum-070, a Polyphenol-Rich Plant Extract, Prevents Hypercholesterolemia in High-Fat Diet-Fed Hamsters by Inhibiting Intestinal Cholesterol Absorption. | Nutrients | 2023 | 38140315 | PubTator, text mining | PubMed |
| Physiologically Based Pharmacokinetic Modeling in Neonates: Current Status and Future Perspectives. | Pharmaceutics | 2023 | 38140105 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8647/papers?page=11